LENSAR, Inc.
News
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company) today announced that a majority of the independent members of LENSARs board of directors granted three newly-hired non-executive employees stock...\n more…
LENSAR to Participate in Two Upcoming Investor Conferences
Business Wire LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company), a global medical technology company focused on advanced laser solutions for the treatment of cataracts, today announced that management will...\n more…
LENSAR, Inc. (LNSR) Q2 2024 Earnings Call Transcript
SeekingAlpha LENSAR, Inc. (LNSR) Q2 2024 Earnings Call Transcript...\n more…
LNSR Stock Earnings: LENSAR Misses EPS, Beats Revenue for Q2 2024
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nLNSR stock results show that LENSAR missed analyst estimates for earnings per share but beat on revenue for the second quarter of...\n more…
LENSAR Reports Second Quarter 2024 Results and Provides Business Update
Business Wire LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company), a global medical technology company focused on advanced laser solutions for the treatment of cataracts, today announced financial results for the...\n more…
LENSAR Announces Certification for the ALLY Adaptive Cataract Treatment System in the European Union
Business Wire LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company), a global medical technology company focused on advanced laser solutions for the treatment of cataracts, today announced that the ALLY Adaptive...\n more…